[Thromboangiitis obliterans (Buerger's disease): update 2015]
Peter Klein-Weigel1, Theresa Sophie Volz1, Jutta Richter2
1Klinik für Angiologie, HELIOS Klinikum Berlin-Buch, Berlin.
Thromboangiitis obliterans (Buerger's disease) is a vascular condition linked to tobacco use. Emerging research suggests autoimmunity plays a role, leading to new therapeutic strategies like progenitor cell therapy.
Area of Science:
- Vascular Biology
- Immunology
- Rheumatology
Background:
- Thromboangiitis obliterans, also known as Buerger's disease, is a rare inflammatory condition affecting blood vessels.
- It is strongly associated with tobacco consumption and typically impacts small and medium arteries and veins.
- The disease exhibits a complex, undulating clinical course.
Purpose of the Study:
- To review the current understanding of the pathophysiology of Thromboangiitis obliterans.
- To highlight the emerging autoimmunity hypothesis for Buerger's disease.
- To discuss novel therapeutic approaches for managing this condition.
Main Methods:
- Literature review of recent research on Thromboangiitis obliterans.
- Analysis of the role of autoimmunologic mechanisms in disease development.
- Compilation of information on emerging treatment modalities.
Main Results:
- The pathophysiology of Thromboangiitis obliterans is increasingly understood to involve autoimmunologic mechanisms.
- An autoimmunity hypothesis is now considered a new paradigm for Buerger's disease.
- Several novel treatments are being explored, including progenitor-cell-therapy and immunoadsorption.
Conclusions:
- The understanding of Thromboangiitis obliterans is evolving, with a shift towards recognizing autoimmune components.
- New therapeutic avenues offer potential for improved management of Buerger's disease.
- Further research into these novel treatments is warranted.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Artery Disease I: Introduction
Venous Thrombosis III: Interprofessional Care
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease IV: Nursing Management
